These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1267439)

  • 1. In vitro susceptibility comparisons and recommendations for oxolinic acid.
    Klein D; Matsen JM
    Antimicrob Agents Chemother; 1976 Apr; 9(4):649-54. PubMed ID: 1267439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of oxolinic acid and nalidixic acid against common urinary pathogens: a comparative study.
    de Rautlin de la Roy Y; Toma V; Bobin B
    Curr Med Res Opin; 1978; 5(9):743-8. PubMed ID: 738079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro studies of nalidixic acid, oxolinic acid, and a new analog with thieno (2,3-b) pyridine structure.
    Gilis PM; Haemers A; Pattyn SR
    Antimicrob Agents Chemother; 1978 Mar; 13(3):533-5. PubMed ID: 263890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activity of miloxacin.
    Izawa A; Kisaki Y; Irie K; Eda Y; Nakagome T; Komatsu T
    Antimicrob Agents Chemother; 1980 Jul; 18(1):37-40. PubMed ID: 7416749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the antibacterial effects of ofloxacin, oxolinic acid and nalidixic acid].
    Langsádl L; Menkyna R; Golier J; Silan L
    Cesk Epidemiol Mikrobiol Imunol; 1988 Sep; 37(5):297-308. PubMed ID: 3197127
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vitro action of oxolinic acid in comparison with nitrofurantoin and nalidixic acid].
    Grima P
    Minerva Urol; 1977; 29(5):225-7. PubMed ID: 611403
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro susceptibility studies with piromidic acid.
    Garcia Rodgriguez JA; Gomez Garcia AC; Saenz Gonzalez MC
    J Antimicrob Chemother; 1978 May; 4(3):289-91. PubMed ID: 670126
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A
    Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative studies of the effect of oxolinic and nalidixic acids on urinary flora].
    Balog F; Këvesh SH; Kochish B
    Urol Nefrol (Mosk); 1974; (6):25-8. PubMed ID: 4446181
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Oxolinic acid in urinary infections.
    Grüneberg RN
    Lancet; 1974 Nov; 2(7888):1088-9. PubMed ID: 4138360
    [No Abstract]   [Full Text] [Related]  

  • 11. [Minimal inhibitory concentration in hospital bacteria].
    Marcenac FM; Fernández AJ; Rebollo MN; Helou HT; Civalero TR; Herran IL; Magri MA
    Rev Asoc Argent Microbiol; 1974; 6(2):44-61. PubMed ID: 4467221
    [No Abstract]   [Full Text] [Related]  

  • 12. High-performance liquid chromatographic method for the simultaneous determination of oxolinic, nalidixic and piromidic acids in cultured fish.
    Horii S; Yasuoka C; Matsumoto M
    J Chromatogr; 1987 Feb; 388(2):459-61. PubMed ID: 3558658
    [No Abstract]   [Full Text] [Related]  

  • 13. Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1983 Jun; 1(2):165-72. PubMed ID: 6232084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.
    Barry AL; Jones RN
    Antimicrob Agents Chemother; 1984 Jun; 25(6):775-7. PubMed ID: 6234858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids.
    Greenwood D
    Antimicrob Agents Chemother; 1978 Mar; 13(3):479-83. PubMed ID: 400825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethoprim enhances the antibacterial activity of nalidixic and oxolinic acids and delays the emergence of resistance.
    Bertolini A; Castelli M; Genedani S; Garuti M
    Experientia; 1980 Feb; 36(2):243-4. PubMed ID: 7371772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparison of the effects of three urinary infection chemotherapeutics - nalidixic, oxolinic, and pipemidic acids (author's transl)].
    Langsádl L; Polívková-Konícková L; Roubínek F
    Cas Lek Cesk; 1979 May; 118(19):588-92. PubMed ID: 498218
    [No Abstract]   [Full Text] [Related]  

  • 18. The antibacterial and pharmacological activity of oxolinic acid (Prodoxol).
    Kershaw MJ; Leigh DA
    J Antimicrob Chemother; 1975 Sep; 1(3):311-5. PubMed ID: 810473
    [No Abstract]   [Full Text] [Related]  

  • 19. Temafloxacin disk potency and tentative interpretive criteria for susceptibility tests.
    Barry AL; Jones RN
    J Clin Microbiol; 1989 Dec; 27(12):2861-3. PubMed ID: 2592548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of nalidixic acid, oxolinic acid and piromidic acid in fish by high-performance liquid chromatography with fluorescence and UV detection.
    Horie M; Saito K; Hoshino Y; Nose N; Mochizuki E; Nakazawa H
    J Chromatogr; 1987 Jul; 402():301-8. PubMed ID: 3654871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.